Literature DB >> 32327034

Emerging Infectious Diseases of Rabbits.

Molly Gleeson1, Olivia A Petritz2.   

Abstract

Recently, multiple infectious organisms have been identified as the cause of emerging diseases in lagomorphs. The most important of these emerging diseases is rabbit hemorrhagic disease virus (RHDV) type 2, a new variant with differences in pathogenicity to classical RHDV. Hepatitis E is considered an emerging zoonotic infectious disease, with widespread prevalence in many different rabbit populations. Mycobacteriosis has been recently reported in other captive domestic rabbit populations. This article provides a recent review of the published literature on emerging infectious diseases in rabbits, including farmed, laboratory, and pet rabbits, some of which have zoonotic potential.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hepatitis E; Mycobacterium; Parvovirus; Picornavirus; Rabbit hemorrhagic disease virus; Zoonoses

Mesh:

Year:  2020        PMID: 32327034     DOI: 10.1016/j.cvex.2020.01.008

Source DB:  PubMed          Journal:  Vet Clin North Am Exot Anim Pract        ISSN: 1094-9194


  3 in total

1.  Preliminary Outbreak Investigation and Spatial Epidemiology of Rabbit Hemorrhagic Disease Outbreak in Nigeria.

Authors:  Muftau Oyewo; Ahmad I Al-Mustapha; Bukola A Richards; Lateefah Abdulkareem; Taiwo Olasoju; Sufiyan M Babale; Hamza Khalid; Clement Meseko; Muhammad S Balogun
Journal:  Front Vet Sci       Date:  2022-01-05

2.  Potent Protease Inhibitors of Highly Pathogenic Lagoviruses: Rabbit Hemorrhagic Disease Virus and European Brown Hare Syndrome Virus.

Authors:  Krishani Dinali Perera; David Johnson; Scott Lovell; William C Groutas; Kyeong-Ok Chang; Yunjeong Kim
Journal:  Microbiol Spectr       Date:  2022-06-29

3.  Outbreak of rabbit hemorrhagic disease virus 2 in the southwestern United States: first detections in southern California.

Authors:  Javier Asin; Akinyi C Nyaoke; Janet D Moore; Viviana Gonzalez-Astudillo; Deana L Clifford; Emma L Lantz; Andrea B Mikolon; Kimberly A Dodd; Beate Crossley; Francisco A Uzal
Journal:  J Vet Diagn Invest       Date:  2021-04-02       Impact factor: 1.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.